Revisit the function of the exocrine pancreas and the possible causes and consequences of EPI.
Find out how to determine an appropriate CREON dose and get tips on how to set treatment expectations with your patients.
See CREON dosing tips and review how to set treatment expectations with patients.
Get educational resources, support program details, and prescription savings information.
Hear from gastroenterologist Shahab Mehdizadeh, MD, as he shares CREON dosing tips.
Review the signs and symptoms of EPI and learn about specific clinical features that can aid your differential diagnosis.
Take a closer look at the underlying conditions and surgical procedures that can cause EPI.
Review the signs and symptoms of EPI and learn about specific clinical features that can aid your differential diagnosis.
Please join us for an AbbVie educational presentation about CREON and EPI. Register today to reserve your space.
CREON & EPI due to chronic pancreatitis, pancreatectomy, or other conditions:
CREON & EPI due to cystic fibrosis:
PERT = pancreatic enzyme replacement therapy.
CREON® (pancrelipase) Delayed-Release Capsules is a pancrelipase which is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.
Please see Full Prescribing Information.
US-CREO-220154
References: 1. CREON [package insert]. North Chicago, IL: AbbVie Inc. 2. IQVIA. IQVIA National Prescription Audit. November 2021. 3. Data on file. North Chicago, IL: AbbVie Inc. October 2019.
